UBS Group
PHAR

UBS Group’s Pharming Group PHAR Stock Holding History

UBS Group’s Portfolio PHAR Stock Details PHAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1
Closed -$18 – 11003
2025
Q4 		$18 Buy
+1
New +$16 ﹤0.01% 10360
2025
Q1 		– Sell
-10
Closed -$101 – 10594
2024
Q4 		$101 Buy
+10
New +$85 ﹤0.01% 9650
2024
Q3 		– Sell
-789
Closed -$6.59K – 9925
2024
Q2 		$6.59K Buy
789
+737
+1,417% +$6.94K ﹤0.01% 7906
2024
Q1 		$546 Buy
+52
New +$615 ﹤0.01% 8486
2023
Q2 		– Sell
-881
Closed -$11.9K – 9462
2023
Q1 		$11.9K Sell
881
-370
-30% -$4.67K ﹤0.01% 7468
2022
Q4 		$13.8K Sell
1,251
-283
-18% -$3.13K ﹤0.01% 8136
2022
Q3 		$15K Buy
1,534
+62
+4% +$626 ﹤0.01% 7821
2022
Q2 		$13K Buy
1,472
+210
+17% +$1.72K ﹤0.01% 7536
2022
Q1 		$11K Sell
1,262
-66
-5% -$585 ﹤0.01% 8313
2021
Q4 		$12K Buy
1,328
+1,214
+1,065% +$10.8K ﹤0.01% 8570
2021
Q3 		$1K Sell
114
-1,205
-91% -$12.8K ﹤0.01% 9221
2021
Q2 		$15K Sell
1,319
-1,189
-47% -$14.8K ﹤0.01% 7645
2021
Q1 		$32K Buy
2,508
+1,592
+174% +$22.2K ﹤0.01% 6959
2020
Q4 		$14K Buy
+916
New +$14K ﹤0.01% 7220

Other funds holding PHAR

SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $240M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group's PHAR Position: Q1 2026 in Review

UBS Group sold out of Pharming Group (PHAR) in Q1 2026, closing a stake of 1 share — an estimated $18 sold.

UBS Group first reported a position in PHAR in Q4 2020 and held it in 14 quarters. The position peaked at $32K in Q1 2021. 12 funds tracked by Wall St. Rank hold PHAR as of Q1 2026.

  • UBS Group reported no remaining Pharming Group position as of Q1 2026 after selling out during the quarter.
  • UBS Group sold 1 Pharming Group share in Q1 2026, an estimated $18.
  • UBS Group first reported a position in Pharming Group in Q4 2020 and held it in 14 quarters.
  • UBS Group's Pharming Group position peaked at $32K in Q1 2021.
  • 12 funds tracked by Wall St. Rank held Pharming Group as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.